Before volume expansion | After volume expansion | p -value | |||
---|---|---|---|---|---|
Heart rate (beat.min −1 ) | |||||
Negative fluid challenges | 72 | [64 – 81] | 71 | [60 – 79] | < 0.001 |
Positive fluid challenges | 67 | [62 – 73] | 62 | [58 – 70] | < 0.001 |
Mean arterial pressure (mmHg) | |||||
Negative fluid challenges | 69 | [57 – 77] | 67 | [57 – 78] | 0.807 |
Positive fluid challenges | 67 | [60 – 71] | 68 | [61 – 73] | 0.210 |
Stroke volume (ml) | |||||
Negative fluid challenges | 38 | [34 – 53] | 40 | [36 – 55] | < 0.001 |
Positive fluid challenges | 37 | [33 – 43] | 43 | [38 – 48] | < 0.001 |
Cardiac output (l.min −1 ) | |||||
Negative fluid challenges | 2.8 | [2.3 – 3.7] | 2.9 | [2.3 – 3.8] | 0.222 |
Positive fluid challenges | 2.5 | [2.0 – 3.1] | 2.9 | [2.3 – 3.3] | < 0.001 |
PPV (%) | |||||
Negative fluid challenges | 12 | [8–15] | 9 | [7–13] | < 0.001 |
Positive fluid challenges | 11 | [9–17] | 8 | [6–11] | < 0.001 |
SVV (%) | |||||
Negative fluid challenges | 14 | [11–20] | 12 | [9–16] | < 0.001 |
Positive fluid challenges | 14 | [11–17] | 9 | [8–12] | < 0.001 |
Remifentanil dose (ng.ml −1 ) | |||||
Negative fluid challenges | 4.0 | [3.0 – 4.6] | 4.0 | [3.0 – 4.6] | - |
Positive fluid challenges | 3.5 | [2.7 – 4.0] | 3.5 | [2.7 – 4.0] | - |
Propofol dose (μg.ml −1 ) | |||||
Negative fluid challenges | 4.0 | [3.8 – 5.0] | 4.0 | [3.8 – 5.0] | - |
Positive fluid challenges | 3.7 | [3.1 – 4.0] | 3.7 | [3.1 – 4.0 | |
ANI mean (n) | |||||
Negative fluid challenges | 70 | [54 – 82] | 77 | [58 – 86] | 0.019 |
Positive fluid challenges | 69 | [62 – 84] | 79 | [66 – 91] | 0.005 |